TRIVELLIN, GIAMPAOLO
 Distribuzione geografica
Continente #
AS - Asia 1.696
NA - Nord America 1.472
EU - Europa 386
SA - Sud America 318
AF - Africa 44
OC - Oceania 11
Totale 3.927
Nazione #
US - Stati Uniti d'America 1.396
SG - Singapore 980
CN - Cina 384
BR - Brasile 265
VN - Vietnam 147
FI - Finlandia 59
IE - Irlanda 59
CA - Canada 46
GB - Regno Unito 45
DE - Germania 37
HK - Hong Kong 34
IT - Italia 34
FR - Francia 28
IN - India 28
RU - Federazione Russa 27
AR - Argentina 24
JP - Giappone 21
MX - Messico 18
BD - Bangladesh 14
CZ - Repubblica Ceca 13
ES - Italia 13
PK - Pakistan 13
BE - Belgio 12
ID - Indonesia 12
AU - Australia 11
IQ - Iraq 10
SE - Svezia 10
ZA - Sudafrica 10
AT - Austria 9
PL - Polonia 9
VE - Venezuela 9
NL - Olanda 8
EC - Ecuador 7
UZ - Uzbekistan 7
DZ - Algeria 6
MA - Marocco 6
TR - Turchia 6
AZ - Azerbaigian 5
CH - Svizzera 5
CL - Cile 5
PH - Filippine 5
TN - Tunisia 5
DO - Repubblica Dominicana 4
EG - Egitto 4
NP - Nepal 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CI - Costa d'Avorio 3
CO - Colombia 3
HU - Ungheria 3
JM - Giamaica 3
KE - Kenya 3
KG - Kirghizistan 3
MY - Malesia 3
UY - Uruguay 3
ET - Etiopia 2
IL - Israele 2
IR - Iran 2
JO - Giordania 2
MD - Moldavia 2
NG - Nigeria 2
NO - Norvegia 2
PE - Perù 2
PS - Palestinian Territory 2
QA - Qatar 2
BB - Barbados 1
DK - Danimarca 1
GT - Guatemala 1
HN - Honduras 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MR - Mauritania 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 3.927
Città #
Singapore 441
San Jose 228
Ashburn 200
Shanghai 192
The Dalles 163
Dallas 90
New York 90
Boardman 82
Beijing 77
Dublin 59
Helsinki 58
Los Angeles 57
Ho Chi Minh City 49
Santa Clara 38
Hanoi 29
Hong Kong 29
São Paulo 27
Phoenix 18
Buffalo 17
Seattle 17
Gatineau 16
Moscow 15
Houston 13
Brno 12
Brooklyn 11
Liège 11
Rio de Janeiro 11
Boston 10
Melbourne 10
Montreal 10
Johannesburg 9
Milan 9
Stockholm 9
Chandler 8
Chicago 8
Lahore 8
Manchester 8
Orem 8
Atlanta 7
Council Bluffs 7
Da Nang 7
Tokyo 7
London 6
Munich 6
Tashkent 6
Vienna 6
Baghdad 5
Baku 5
Charlotte 5
Curitiba 5
Guarulhos 5
Haiphong 5
Naples 5
Porto Alegre 5
Southwark 5
Toronto 5
Warsaw 5
Washington 5
Assago 4
Belo Horizonte 4
Buenos Aires 4
Can Tho 4
Chennai 4
Denver 4
Fortaleza 4
Frankfurt am Main 4
Higashiosaka 4
Hải Dương 4
Mexico City 4
Nashville 4
New Delhi 4
Quito 4
San Francisco 4
St Petersburg 4
São José dos Campos 4
Abidjan 3
Amsterdam 3
Bishkek 3
Bến Tre 3
Campinas 3
Caxias do Sul 3
Guayaquil 3
Hangzhou 3
Kuala Lumpur 3
La Marque 3
Leiden 3
Manaus 3
Miami 3
Monterrey 3
Nairobi 3
Newark 3
Ninh Bình 3
Paris 3
Soissons 3
Sorocaba 3
Tirana 3
Torres 3
Vũng Tàu 3
Addis Ababa 2
Amman 2
Totale 2.400
Nome #
Use of G protein-coupled receptor 101 inhibitor, antagonist or inverse agonist for prevention and/or therapeutic treatment of diseases selected from group consisting of acromegaly and gigantism 171
Characterization of GPR101: Transcripts Structure, Expression Pattern, and Signal Transduction Pathways 133
Alteration of the immunophenotype and cytokine profiles in patients affected by neuroendocrine neoplasms 87
Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management 87
Characterization of GPR101 Expression Across Different Species 83
Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia 77
X-Linked Acro-Gigantism (X-LAG) Due to Microduplications of Chromosome Xq26: A New Disorder and Implications for Acromegaly 73
X-linked acro-gigantism (X-LAG): a new form of infant-onset pituitary gigantism 72
Filamin A is involved in human intrahepatic cholangiocarcinoma aggressiveness and progression 63
miR-107 inhibits the expression of aryl hydrocarbon receptor interacting protein (AIP) and is potentially involved in pituitary tumorigenesis 63
A novel truncating AIP mutation, p.W279*, in a familial isolated pituitary adenoma (FIPA) kindred 63
CD40LG duplications in patients with X-LAG syndrome commonly undergo random X-chromosome inactivation 62
Comparing models and experimental structures of the GPR101 receptor: Artificial intelligence yields highly accurate models 61
A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers 59
AIP and its interacting partners 58
Characterization of GPR101 transcript structure and expression patterns 58
Xq26.3 Duplication in a Boy With Motor Delay and Low Muscle Tone Refines the X-Linked Acrogigantism Genetic Locus 57
GPR101: Modeling a constitutively active receptor linked to X-linked acrogigantism 57
Chaperones, somatotroph tumors and the cyclic AMP (cAMP)-dependent protein kinase (PKA) pathway 57
Neurofibromatosis Type 1 Has a Wide Spectrum of Growth Hormone Excess 56
Characterization of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Mutations in Familial Isolated Pituitary Adenoma Families 54
An orphan G-protein-coupled receptor causes human gigantism and/or acromegaly: Molecular biology and clinical correlations 54
cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors 53
Chromatin conformation capture in the clinic: 4C-seq/HiC distinguishes pathogenic from neutral duplications at the GPR101 locus 51
Germline mutations in a G protein identify signaling cross-talk in T cells 50
Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion 49
Characterization of the adiponectin promoter + Cre recombinase insertion in the Tg(Adipoq-cre)1Evdr mouse by targeted locus amplification and droplet digital PCR 49
Increased expression of miR-34a explains the low AIP protein level present in 50% of sporadic somatotropinomas 48
PAM variants in patients with thyrotrophinomas, cyclical Cushing's disease and prolactinomas 48
A Novel Mutation in the Upstream Open Reading Frame of the CDKN1B Gene Causes a MEN4 Phenotype 48
Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up 48
The impact of SST2 trafficking and signaling in the treatment of pancreatic neuroendocrine tumors 48
FAF1 Gene Involvement in Pituitary Corticotroph Tumors 48
Interaction of AIP with protein kinase A (cAMP-dependent protein kinase) 47
AIP Mutation in Pituitary Adenomas REPLY 47
Evaluation of CDKN1B germline mutations in a cohort of acromegalic patients with evidences of multiple neoplasia 47
Cyclic 3',5'-adenosine monophosphate (cAMP) signaling in the anterior pituitary gland in health and disease 47
Genetics of gigantism and acromegaly 47
The R304X mutation of the Aryl hydrocarbon receptor Interacting Protein gene in familial isolated pituitary adenomas: mutational Hot-Spot or founder effect? 46
Characterization of SNARE Proteins in Human Pituitary Adenomas: Targeted Secretion Inhibitors as a New Strategy for the Treatment of Acromegaly? 46
Role of Phosphodiesterases on the Function of Aryl Hydrocarbon Receptor-Interacting Protein (AIP) in the Pituitary Gland and on the Evaluation of AIP Gene Variants 46
Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome 46
Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism 46
MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro 45
Structure of the TPR Domain of AIP: Lack of Client Protein Interaction with the C-Terminal alpha-7 Helix of the TPR Domain of AIP Is Sufficient for Pituitary Adenoma Predisposition 45
Increased Population Risk of AIP-Related Acromegaly and Gigantism in Ireland 44
Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing's disease 43
The direct impact of pegvisomant on osteoblast functions and bone development 42
The Glucose-Dependent Insulinotropic Polypeptide Receptor is Overexpressed Amongst GNAS1 Mutation-Negative Somatotropinomas and Drives Growth Hormone (GH)-Promoter Activity in GH3 Cells 42
MicroRNAs: Suggested role in pituitary adenoma pathogenesis 41
SATB1: a gene involved in pituitary development may have a role in somatotroph tumors 41
Evaluation of p27KIP1 germline mutations in familial phaeochromocytoma and clinically suspected MEN1 patients 41
Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway 40
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 40
Oncogene-induced senescence in pituitary adenomas and carcinomas 39
Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations 39
Evaluation of mutations in aryl hydrocarbon receptor interacting protein (AIP) in acromegalic sporadic cases and in one FIPA family 39
Hereditary endocrine tumours: Current state-of-the-art and research opportunities: GPR101, an orphan GPCR with roles in growth and pituitary tumorigenesis 38
Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers 38
The X-linked acrogigantism-associated gene gpr101 is a regulator of early embryonic development and growth in zebrafish 37
Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study 37
Large genomic aberrations in corticotropinomas are associated with greater aggressiveness 37
GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone Deficiency 36
Diagnosis and Treatment of Parasellar Lesions 36
Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients 36
Familial pituitary apoplexy as the only presentation of a novel AIP mutation 35
Stable GPR101 over-expressing cell lines as an invaluable tool for functional studies, ligand screening, and the identification of deregulated genes/pathways in patients with X-linked acrogigantism 35
Screening for GPR101 defects in pediatric pituitary corticotropinomas 34
Macronodular Adrenal Hyperplasia due to Mutations in an Armadillo Repeat Containing 5 (ARMC5) Gene: A Clinical and Genetic Investigation 34
Genetics, clinical features and outcomes of non-syndromic pituitary gigantism: experience of a single center from Sao Paulo, Brazil 34
Gigantism, Acromegaly, and GPR101 Mutations REPLY 34
Prkar1a haploinsufficiency ameliorates the growth hormone excess phenotype in Aip-deficient mice 34
Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation 33
MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics 32
Familial isolated pituitary adenomas: An emerging clinical entity 32
Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas 31
GHRH excess and blockade in X-LAG syndrome 31
Pituitary gigantism: update on molecular biology and management 30
Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects 28
IGSF1 Deficiency Results in Human and Murine Somatotrope Neurosecretory Hyperfunction 27
Hereditary endocrine tumours: Current state-of-the-art and research opportunities: The roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA) 27
Is IGSF1 involved in human pituitary tumor formation? 27
Totale 4.024
Categoria #
all - tutte 24.239
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.239


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210 0 0 0 0 0 0 0 0 1 4 4 1
2022/202396 4 2 2 2 3 2 0 1 6 4 0 70
2023/2024706 50 31 145 21 36 80 90 50 13 24 61 105
2024/2025952 37 4 18 15 11 139 113 54 94 220 129 118
2025/20262.260 321 143 120 234 131 129 622 116 113 143 114 74
Totale 4.024